1887

Journal of General Virology header logo

Volume 82, Issue 9

The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence Free

Abstract

Vaccinia virus (VV) gene A41L encodes an acidic protein with amino acid similarity to the 35 kDa protein of VV strain Lister, a soluble protein called vCKBP that binds CC chemokines, and to a protein from orf virus, called GIF, that binds GM-CSF and IL-2. However, despite the similarity, recombinant A41L protein was found not to bind these ligands or a variety of other chemoattractant molecules when tested using surface plasmon resonance. The A41L gene is expressed early and late during infection and encodes a 30 kDa protein that contains both - and -linked carbohydrate and is secreted from the infected cell. All 16 strains of VV and 2 strains of cowpox virus that were tested express the A41L protein, implying it has an important function for orthopoxviruses. Nonetheless, a VV strain Western Reserve deletion mutant lacking the A41L gene (vΔA41L) formed normal sized plaques and replicated to the same titre as wild-type and revertant viruses. The importance of the A41L protein was demonstrated in a mouse intradermal model in which infection with vΔA41L caused more severe lesions compared to wild-type and revertant viruses. Further examination in this model revealed that deletion of A41L enhanced clearance of infectious virus, suggesting that A41L expression reduces immunopathology. Consistent with this, histological examination of infected rabbit skin showed that the A41L protein could reduce the infiltration of inflammatory cells into the infected area. Together, these data suggest that the A41L protein constitutes a novel immunomodulatory protein.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-9-2095
2001-09-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/9/0822095a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-9-2095&mimeType=html&fmt=ahah

References

  1. Aguado B., Selmes I. P., Smith G. L. 1992; Nucleotide sequence of 21·8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. Journal of General Virology 73:2887–2902
     [Google Scholar]
  2. Alcamí A., Kosinowski U. 2000; Viral immune evasion strategies. Immunology Today 21:447–455
     [Google Scholar]
  3. Alcamí A., Smith G. L. 1995; Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. Journal of Virology 69:4633–4639
     [Google Scholar]
  4. Alcamí A., Symons J. A., Collins P. D., Williams T. J., Smith G. L. 1998; Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. Journal of Immunology 160:624–633
     [Google Scholar]
  5. Alcamí A., Khanna A., Paul N. L., Smith G. L. 1999; Vaccinia virus strains Lister, USSR and Evans express soluble and cell surface tumour necrosis factors receptor. Journal of General Virology 80:949–959
     [Google Scholar]
  6. Alcamí A., Symons J. A., Smith G. L. 2000; The vaccinia soluble IFN-α/β receptor binds to the cell surface and protects cells from the anti-viral effects of IFN. Journal of Virology 74:11230–11239
     [Google Scholar]
  7. Antoine G., Scheiflinger F., Dorner F., Falkner F. G. 1998; The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365–396
     [Google Scholar]
  8. Boyle D. B., Coupar B. E. H. 1988; A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123–128
     [Google Scholar]
  9. Carfí A., Smith C. A., Smolak P. J., McGrew J., Wiley D. C. 1999; Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proceedings of the National Academy of Sciences, USA 96:12379–12383
     [Google Scholar]
  10. Comeau M. R., Johnson R., DuBose R. F., Petersen M., Gearing P., VandenBos T., Park L., Farrah T., Buller R. M., Cohen J. I., Strockbine L. D., Rauch C., Spriggs M. K. 1998; A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8:473–482
     [Google Scholar]
  11. Czerny C. P., Mahnel H. 1990; Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies. Journal of General Virology 71:2341–2352
     [Google Scholar]
  12. Deane D., McInnes C., Percival A., Wood A., Thomson J., Lear A., Gilray J., Fleming S., Mercer A., Haig D. 2000; Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. Journal of Virology 74:1313–1320
     [Google Scholar]
  13. Devereux J., Haeberli P., Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
     [Google Scholar]
  14. Falkner F. G., Moss B. 1988; Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. Journal of Virology 62:1849–1854
     [Google Scholar]
  15. Falkner F. G., Moss B. 1990; Transient dominant selection of recombinant vaccinia viruses. Journal of Virology 64:3108–3111
     [Google Scholar]
  16. Fenner F., Anderson D. A., Arita I., Jezek Z., Ladnyi I. D. 1988 Smallpox and its Eradication Geneva: World Health Organization;
  17. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P., Paoletti E. 1990; The complete DNA sequence of vaccinia virus. Virology 179:247–266
     [Google Scholar]
  18. Graham K. A., Lalani A. S., Macen J. L., Ness T. L., Barry M., Liu L., Lucas A., Clark-Lewis I., Moyer R. W., McFadden G. 1997; The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12–24
     [Google Scholar]
  19. Howard S. T., Chan Y. S., Smith G. L. 1991; Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180:633–647
     [Google Scholar]
  20. Hughes S. J., Johnston L. H., de Carlos A., Smith G. L. 1991; Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. Journal of Biological Chemistry 266:20103–20109
     [Google Scholar]
  21. Johnson G. P., Goebel S. J., Paoletti E. 1993; An update on the vaccinia virus genome. Virology 196:381–401
     [Google Scholar]
  22. Kerr S. M., Smith G. L. 1991; Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. Virology 180:625–632
     [Google Scholar]
  23. Mackett M., Smith G. L. 1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proceedings of the National Academy of Sciences, USA 79:7415–7419
     [Google Scholar]
  24. Mackett M., Smith G. L., Moss B. 1985; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach pp 191–211 Edited by Glover D. M. Oxford: IRL Press;
     [Google Scholar]
  25. Massung R. F., Liu L., Qi J., Knight J. C., Yuran T. E., Kerlavage A. R., Parsons J. M., Venter J. C., Esposito J. J. 1994; Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology 201:215–240
     [Google Scholar]
  26. Moss B. 1996; Poxviridae : the viruses and their replication. In Fields Virology pp 2637–2671 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  27. Nicholas K. B., Nicholas H. B. Jr., Deerfield D. W.II. 1997; GeneDoc: analysis and visualization of genetic variation. EMBNEW NEWS 4:14
     [Google Scholar]
  28. Parkinson J. E., Smith G. L. 1994; Vaccinia virus gene A36R encodes a Mr 43–50 K protein on the surface of extracellular enveloped virus. Virology 204:376–390
     [Google Scholar]
  29. Patel A. H., Gaffney D. F., Subak-Sharpe J. H., Stow N. D. 1990; DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. Journal of General Virology 71:2013–2021
     [Google Scholar]
  30. Shchelkunov S. N., Blinov V. M., Resenchuk S. M., Totmenin A. V., Olenina L. V., Chirikova G. B., Sandakhchiev L. S. 1994; Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola virus strain India-1967. Virus Research 34:207–236
     [Google Scholar]
  31. Smith G. L., Chan Y. S., Howard S. T. 1991; Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. Journal of General Virology 72:1349–1376
     [Google Scholar]
  32. Smith C. A., Smith T. D., Smolak P. J., Friend D., Hagen H., Gerhart M., Park L., Pickup D. J., Torrance D., Mohler K., Schooley K., Goodwin R. G. 1997; Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316–327
     [Google Scholar]
  33. Smith G. L., Symons J. A., Khanna A., Vanderplasschen A., Alcamí A. 1997; Vaccinia virus immune evasion. Immunological Reviews 159:137–154
     [Google Scholar]
  34. Spriggs M. K. 1996; One step ahead of the game: viral immunomodulatory molecules. Annual Review of Immunology 14:101–130
     [Google Scholar]
  35. Thompson J. D., Higgins D. G., Gibson T. J. 1994; CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Research 22:4673–4680
     [Google Scholar]
  36. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA 76:4350–4354
     [Google Scholar]
  37. Tscharke D. C., Smith G. L. 1999; A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. Journal of General Virology 80:2751–2755
     [Google Scholar]
  38. Upton C., DeLange A. M., McFadden G. 1987; Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology 160:20–30
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-9-2095
Loading
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence
J. Gen. Virol. 82, 2095 (2001); https://doi.org/10.1099/0022-1317-82-9-2095
/content/journal/jgv/10.1099/0022-1317-82-9-2095
/content/journal/jgv/10.1099/0022-1317-82-9-2095
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error